Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 27, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Shares Purchased | 699,294 |
| Highest Price Paid | 372.00 pence |
| Lowest Price Paid | 369.20 pence |
| Volume Weighted Average Price | 370.7933 pence |
| Registered Share Capital (Post-Settlement) | 9,124,886,258 ordinary shares |
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of 699,294 ordinary shares. The filing does not provide comparative data against prior periods for financial performance.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the Market Abuse Regulation. The transaction was executed in accordance with the company's announced buyback programme.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 1, 2024, Buyback Programme.
- Confirm the remaining authorized share buyback limit and the programme's end date.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution details.
- Check the company's website for updated investor relations materials regarding the impact of the buyback on earnings per share.